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Abstract
Hippocampal sclerosis (HS) is a common pathological finding in patients with temporal lobe epilepsy (TLE) and is associated
with altered expression of genes controlling neuronal excitability, glial function, neuroinflammation and cell death.
MicroRNAs (miRNAs), a class of small non-coding RNAs, function as post-transcriptional regulators of gene expression and
are critical for normal brain development and function. Production of mature miRNAs requires Dicer, an RNAase III, loss of
which has been shown to cause neuronal and glial dysfunction, seizures, and neurodegeneration. Here we investigated
miRNA biogenesis in hippocampal and neocortical resection specimens from pharmacoresistant TLE patients and autopsy
controls. Western blot analysis revealed protein levels of Dicer were significantly lower in certain TLE patients with HS. Dicer
levels were also reduced in the hippocampus of mice subject to experimentally-induced epilepsy. To determine if Dicer loss
was associated with altered miRNA processing, we profiled levels of 380 mature miRNAs in control and TLE-HS samples.
Expression of nearly 200 miRNAs was detected in control human hippocampus. In TLE-HS samples there was a large-scale
reduction of miRNA expression, with 51% expressed at lower levels and a further 24% not detectable. Primary transcript (pri-
miRNAs) expression levels for several tested miRNAs were not different between control and TLE-HS samples. These findings
suggest loss of Dicer and failure of mature miRNA expression may be a feature of the pathophysiology of HS in patients
with TLE.
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Introduction
MicroRNAs (miRNAs) are a class of small (,22 nucleotide)
non-coding RNA which function as post-transcriptional regulators
of gene expression by targeting protein-coding mRNAs [1]. In
humans, mature miRNAs are transcribed by RNA polymerase II/
III to form a primary transcript (pri-miRNA) which is then
processed by the RNaseIII Drosha to pre-miRNA [2,3]. After
export to the cytoplasm, mature miRNA is produced by the action
of Dicer, another RNaseIII, which generates a double-stranded
miRNA from which one strand is forwarded to the RNA-induced
silencing complex [3,4]. Here, Argonaute (AGO) proteins in-
cluding AGO2 perform miRNA-mediated translational repression
via mRNA destabilization and degradation [3,4].
miRNAs are abundantly expressed in the human brain and are
essential for normal brain development and function [5].
Experimental deletion of Dicer from neurons results in spine loss,
apoptosis and functional deficits [6,7,8]. Dicer deletion from
astrocytes triggers seizures as well as a degenerative phenotype [9].
Accordingly, altered miRNA expression may contribute to CNS
pathologies and loss of Dicer and specific miRNAs, including miR-
133b and miR-9, has been reported in neurodegenerative diseases
[10,11,12].
Temporal lobe epilepsy (TLE) is a common, chronic
neurologic disorder characterized by recurrent spontaneous
seizures which originate in brain structures such as the
hippocampus [13]. Hippocampal sclerosis (HS) is often present
in patients with refractory TLE, comprising neuron loss and
gliosis within the CA1, CA3, hilus/CA4, often accompanied by
dispersion of the granule cell layer [14,15]. Loss of neurons is less
common in the neocortex of TLE patients [16,17]. Dysregulation
of genes affecting neurotransmission, gliosis, neuroinflammation
and apoptosis has been proposed to underlie the pathogenesis of
TLE with HS [18,19,20] but our understanding of the
mechanisms remains incomplete.
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Given the phenotypes resulting from loss of Dicer and/or
miRNAs from brain, we hypothesized that HS in patients with
TLE may be associated with alterations in miRNA processing. We
report Dicer levels are reduced in human TLE-HS tissue and this
is associated with large-scale reductions in levels of mature
miRNAs. These findings indicate a potential failing of mature
miRNA production in the sclerotic hippocampus of TLE patients.
Results
Reduced Dicer Levels in Human TLE with HS
Human autopsy control and TLE patient clinical data are
reported in Tables 1 and 2. The average age of TLE patients was
37.2 years which was not different from autopsy controls (31.6
years; P= 0.236) and each group included males and females.
Nissl-stained sections from autopsy controls displayed typical
hippocampal architecture (Fig. 1A). In contrast, HS samples from
TLE patients displayed extensive pyramidal neuron loss and
gliosis, with some also showing granule neuron dispersal
(Figure 1A, Table 2).
Hippocampal samples from TLE patients were divided into two
sets for further analysis (TLE1–4 and TLE5–8), with the samples
displaying the most severe HS being in the first group (see Table 2,
Figure 1B). Confirming pathological observations, Western blot
analysis showed levels of the mature neuron marker NeuN were
significantly lower in HS samples from TLE patients 1–4
compared to controls (Figure 1B, C). Protein levels of glial
fibrillary acidic protein (GFAP), an astrocyte marker, were
significantly higher in these TLE-HS samples compared to
controls (Figure 1B, C).
Next, we examined hippocampal levels of key enzymes in the
miRNA biogenesis pathway. Dicer was detected at its predicted
weight of ,220 kD in all control samples (Figure 1D). In contrast,
Dicer levels were significantly lower in TLE-HS samples
(Figure 1D, E). We also detected higher levels of a lower-weight
Dicer species, presumably cleaved Dicer in TLE-HS samples
(Figure S1A).
Drosha, which processes pri-miRNA into pre-miRNA [2], was
detected at ,160 kD in control and HS samples from TLE
patients. There was no significant difference in protein levels
between the groups (Figure 1D, E). AGO2 was detected in control
hippocampus and protein levels were significantly higher in HS
samples from patients with TLE (Figure 1D, E).
Reduced Mature miRNA Expression in Human TLE with
HS
Since Dicer is a critical enzyme in the production of mature
miRNAs we hypothesized that mature miRNA levels may be
reduced in TLE-HS samples. To test this, we profiled mature
miRNA levels in hippocampus from controls (C1–4) and the
samples from TLE patients displaying reduced Dicer (TLE 1, 2
and 4; sample 3 was omitted due to insufficient material; see
Methods for details). Using Taqman low density arrays (TLDA)
[21] we screened 380 human miRNAs of which 198 miRNAs
(52.1%) were called present in control human hippocampus
(Figure 2A and data not shown). The 40 most abundantly
expressed miRNAs in human autopsy control hippocampus, based
on Ct values, are presented in Table S1. The expression of
miRNAs was substantially different in HS tissue from TLE
patients (Figure 2A–C). Only 150 miRNAs were called present in
TLE-HS samples, with 48 (24.2%) of the control-expressed
miRNAs not detected. No miRNAs were detected in TLE-HS
samples but not controls. Of the expressed miRNAs, 39 (19.7% of
those present in controls) showed no difference in expression from
control (,1.5 fold difference), while 101 (51.0% of the number in
controls or 67.3% of those expressed in TLE-HS) were present at
lower levels than in controls (Figure 2A, B, C). Among the down-
regulated miRNAs, 37 of the 150 were significantly different from
controls (Figure 2C). Only 10 miRNAs were expressed at higher
levels in TLE samples than in controls (Figure 2B and Figure S2).
Pri-miRNA Expression is not Reduced in Human TLE-HS
We next measured pri-miRNA transcript levels for a selection of
miRNAs which displayed significantly reduced mature levels in
TLE-HS (Figure 2C, D). Measurement of pri-miRNA transcript
levels for four pri-miRNAs (,10% of those significantly reduced in
the mature miRNA screen) revealed no significant differences
between TLE-HS samples and controls for pri-miR-181d, pri-
miR-130a, pri-miR-let-7d and pri-miR-23b (Figure 2D and data
not shown).
As a control to ensure mature miRNA differences were not the
result of an autopsy-related change in miRNA levels, we simulated
a post-mortem interval using mouse brain (Figure S3). Levels of
three mature miRNAs tested did not change with an autopsy delay
of up to 8 h (Figure S3A). Levels of Dicer protein were reduced as
a function of simulated autopsy delay whereas levels of Ago2
protein increased with simulated autopsy delay time (Figure S3B).
Simulated autopsy delay had no effect on protein levels of Drosha
(Figure S3B).
Bioinformatics Analysis of Pathways Impacted by
Reduced Mature miRNA Expression in TLE-HS
To gain insight into how the suppressed miRNA profile in TLE-
HS tissue might affect signalling pathways we identified potential
mRNA targets of the significantly down-regulated miRNAs (see
Methods, Figure S4). For cellular component, genes associated
with the nucleus were predicted to be most impacted. Among
biological processes and molecular function, the pathways
Table 1. Autopsy control details.
Identifier Gender Age, y Tissue Cause of death PMI, h
C1 M 42 Hippocampus Multiple injuries, road traffic accident 8
C2 M 37 Hippocampus Arteriosclerotic cardiovascular disease, ruptured
aortic aneurysm
12
C3 M 28 Hippocampus and T.L. neocortex Multiple injuries, road traffic accident 7
C4 F 26 Hippocampus and T.L. neocortex Cardiac tamponade 12
C5 F 25 T.L. neocortex Multiple injuries, road traffic accident 7
Key: F, female; h, hours; M, male; PMI, post-mortem interval; T.L., temporal lobe; y, years.
doi:10.1371/journal.pone.0035921.t001
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predicted to be affected included nucleic acid metabolism and
transcriptional regulation (Figure S4).
Normal Dicer Levels in Human TLE Neocortex
Levels of Dicer, Drosha and AGO2 in the second set of TLE
samples in which hippocampal pathology was moderate/minimal
(see Table 2) were not significantly different from controls (data
not shown). Dicer and Drosha levels in human neocortex were also
not significantly different between TLE patients and controls
(Figure 3A, B). AGO2 levels were significantly higher in TLE
neocortex samples compared to controls (Figure 3A, B).
Loss of Hippocampal Dicer in Experimental TLE
To support the patient findings, we measured Dicer levels in the
sclerotic hippocampus of epileptic mice. Epilepsy was induced by
stereotaxic microinjection of kainic acid into the amygdala to
trigger status epilepticus. This results in the emergence of
recurrent spontaneous seizures in all animals within the first week
and continuing thereafter [22]. Consistent with previous reports
[22,23], tissue sections from mice 21 days after status epilepticus
displayed neuron loss and astrogliosis within the CA3 subfield
(Figure 3C, D). This was supported by Western blot analysis of
NeuN and GFAP levels (Figure 3E).
Dicer levels were significantly lower in hippocampal CA3
samples from epileptic mice (Figure 3F, G). In addition, there were
higher levels of cleaved Dicer (Figure S1B). Hippocampal levels of
Drosha and Ago2 were not different between controls and
epileptic mice (Figure 3F and data not shown). Dicer levels were
not changed in the hippocampus by brief, non-damaging seizures
induced in mice by intraperitoneal injection of a low-dose of kainic
acid (Figure 3H).
Discussion
Dicer is essential for production of most mature miRNAs and its
loss from neurons or astrocytes results in miRNA down-regulation,
neuronal dysfunction and apoptosis, seizures and cognitive deficits
[6,7,9]. Thus, the phenotype of Dicer deletion shares important
commonalities with the hallmarks of TLE and its underlying
pathophysiology [13,15,18]. Altered miRNA expression has been
suggested to be a causal factor in several CNS diseases
[10,11,12,24] but the present study is the first to both investigate
miRNA biogenesis and profile miRNA expression in human TLE.
We found a selective reduction in Dicer levels in tissue from TLE
patients with severe HS. We also found Dicer levels were reduced
in experimental TLE-HS. Since Dicer levels were normal in less
sclerotic human TLE tissue, and are not changed after status
epilepticus [21] or brief non-harmful seizures (Figure 3H), the loss
of Dicer appears specific to TLE with HS. These findings
represent a significant advance on previous work that showed
dysregulation of miRNAs after seizures and in epilepsy
[21,25,26,27]. Given the pathological consequences of Dicer loss
in brain [6,7,9,10] we speculate that loss of Dicer may contribute
to the pathogenesis of TLE-HS. Hippocampal sclerosis therefore
appears to share loss of Dicer in common with certain
neurodegenerative diseases [28,29].
Table 2. TLE patient clinical and pathological details.
Identifier Gender Age, y Tissue Diagnosis and other pathology findings
E1 M 37 Hippocampus Hippocampal sclerosis; Specimen comprises dentate fascia and pyramidal cell
layer. Loss of cells in dentate fascia, and considerable loss of pyramidal cells with
accompanying gliosis
E2 M 23 Hippocampus Hippocampal sclerosis; Specimen comprises pyramidal layer and dentate fascia.
Minimal GCD, severe pyramidal neuron loss in CA2 and CA3 with accompanying
astrogliosis
E3 M 39 Hippocampus Hippocampal sclerosis; Specimen contains hippocampus, dentate fascia with
dispersal of neurons, but pyramidal layer not included
E4 F 31 Hippocampus Hippocampal sclerosis (mild); Specimen comprises dentate fascia, CA4 and CA3
regions showing moderate gliosis (GFAP histochemistry)
E5 F 34 Hippocampus Hippocampal gliosis; Specimen comprises hippocampus including dentate
fascia and CA4 and showing moderate gliosis (GFAP histochemistry). No
evidence of tumor, infection or vascular malformation
E6 F 43 Hippocampus Hippocampal gliosis; Specimen comprises dentate fascia and CA4 region. Focal
gliosis in CA4 region
E7 M 29 Hippocampus Specimen comprises dentate fascia and pyramidal cell layer. Astrocytic
hyperplasia with pyramidal cell layer with neuron loss
E8 M 48 Hippocampus Hippocampal gliosis; Specimen comprises dentate fascia and hippocampal
pyramidal cell layer. Very minor degree of astrocytic hyperplasia (white matter).
Pyramidal layer reasonably well populated with neurons, no evidence of any
dispersal of neurons in the dentate fascia
E9 M 27 T.L. neocortex Normal cortical laminar pattern, cyto-architecture well maintained, no evidence
of any inflammatory or neoplastic process and no evidence of gliosis or other
epilepsy-associated lesion
E10 M 53 T.L. neocortex Unremarkable although changes to subcortical white matter include foci of
hypercellularity (astrocytes and oligodendroglia and endothelial hyperplasia.
Some dysplastic neurons
E11 M 45 T.L. neocortex Normal. Hexilaminar pattern, normal subcortical white matter, no cortical
dysplasia or neuronal ectopia, no inflammatory process or abnormal vessels
Key; F, female; GCD, granule cell dispersion; M, male; T.L. temporal lobe; y, years.
doi:10.1371/journal.pone.0035921.t002
Loss of Dicer and MicroRNAs in Human Epilepsy
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e35921
We do not know the cause of Dicer loss but since Dicer is
expressed in neurons [30] the finding may simply reflect severe
neuron loss in the tissue. Other biogenesis components,
however, did not show reduced levels and astrocytes, which
also express Dicer [9], were increased in HS tissue. Indeed, the
selective deletion of Dicer from neurons only reduces hippo-
campal protein levels by ,60%, presumably due to residual
glial Dicer [8]. Taken together, this favors a more specific cause
of the down-regulation. In addition to possible transcriptional
downregulation, Dicer is known to be a substrate for cleavage-
dependent inactivation by caspases [31] and caspases are
activated in HS tissue from TLE patients [20]. Caspase-
mediated Dicer cleavage can also convert Dicer into a pro-
apoptotic DNase [32] and cells positive for DNA fragmentation
are present in resected TLE material [33,34]. We detected
possible Dicer cleavage in both human and experimental
epilepsy, although the lower-weight species was most similar
to a reported calpain-generated fragment [30]. Identifying ways
to rescue Dicer or block its down-regulation could offer a means
to reconstitute miRNA expression in HS tissue.
Figure 1. Reduced Dicer levels in TLE patients with hippocampal sclerosis. (A) Representative histology for autopsy controls and patient
samples. (a) Photomicrograph showing field view of a cresyl violet-stained section from an autopsy control hippocampus (C2). (b) Photomicrograph
showing a field view of the hippocampus from a TLE-HS patient (E2). Boxes in b indicate regions of the section from which higher-power images and
other stains in c–e are presented. (c) Evident pyramidal neuron loss in the CA1 sector (206 lens). (d) Granule cell layer dispersion in E2. (e) GFAP
immunohistochemistry showing astrogliosis within the granule cell layer. (f, g) Cresyl violet and GFAP-stained sections from patient E3 showing
granule cell layer dispersion and astrogliosis (206 lens). Scale bar in a, b, 1 mm; c–g, 100 mm. (B) Representative Western blots showing protein levels
of neuron (NeuN) and astrocyte (GFAP) markers in hippocampus from controls (C1–4) and TLE-HS patients (E1–4). (C) Semi-quantification of protein
levels (n= 4 per group). Levels of the uppermost band (,66 kD) and a lower band (48 kD) were lower in TLE-HS samples, whereas GFAP (uppermost
band analyzed) was higher. (D, E) Representative Western blots and graphs showing protein levels and semi-quantification for Dicer, Drosha and
AGO2. *p,0.05; **p,0.01 compared to controls. Protein levels corrected to a-Tubulin (a-Tub).
doi:10.1371/journal.pone.0035921.g001
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AGO2 levels were higher in human TLE-HS and neocortex,
suggesting epileptic seizures may up-regulate AGO2. The
temporal cortex samples from TLE patients displayed normal
levels of both Dicer and Drosha. It is notable that AGO2 is
capable of processing certain miRNAs without Dicer, including
miR-451 [35,36], and miR-451 was among the few upregulated
miRNAs in TLE-HS tissue. Thus, elevated AGO2 in human TLE
may contribute to maintaining levels of this miRNA.
Recent work suggests there are about 600 miRNAs expressed in
the human brain, although a collection of ,20 miRNAs account
for nearly 90% [37]. The present study included profiling of
mature miRNA expression in normal human autopsy hippocam-
pus, and nearly 200 were detected. Among those expressed, 15
have previously been reported as abundant in human dorsolateral
prefrontal cortex [37], including miR-26a and miR-125b. Among
other abundant miRNAs were known brain-enriched miRNAs,
including miR-9 [38], and miR-132 [8] and astrocyte-expressed
miRNAs such as miR-29a [39].
The second major finding in the present study was that TLE-
HS tissue displayed lower expression of many mature miRNAs.
Two-thirds of the detected miRNAs were present at lower levels
than in controls, and nearly a quarter of the control-expressed
miRNAs were not detected in TLE-HS samples. This indicates
a failure or collapse of mature miRNA expression in human
TLE-HS. Our data are in congruence, therefore, with the effect
of experimental inactivation of Dicer which results in reduced
levels of many, but not all, miRNAs [6,7,40,41]. The similar
level of several pri-miRNAs and Drosha in TLE-HS is also
supportive of the defect in mature miRNA production being at
the level of Dicer. Notably, miR-486 levels do not change in the
hippocampus after Dicer loss [8] and this miRNA was not
differently expressed in TLE-HS in our study. The persistence of
some mature miRNA production in the sclerotic hippocampus
may be due to residual Dicer activity, longevity of the mature
miRNAs in hippocampus after Dicer loss [7,8], or compensation
by other proteins within the miRNA biogenesis pathway [35,36].
Although loss of Dicer is the most obvious explanation for the
observed large-scale reduction in miRNA levels, differences in
expression of other miRNA biogenesis components such as the
Drosha partner DiGerorge syndrome chromosome 8 (DGCR8)
or Dicer partner transactivating response RNA-binding protein
(TRBP), would also be likely to affect mature miRNA levels
Figure 2. Reduced mature miRNA expression in human TLE-HS. (A) Heat-map depiction of raw miRNA expression data for 188 of the
expressed miRNAs from controls (C1–C4) and TLE-HS samples (TLE1, TLE2 and TLE4). Note the reduction in miRNA levels (green bars) in TLE-HS
samples. Scale bar to left indicates fold differences. (B) Pie chart summarizing the findings from profiling miRNA levels in human TLE-HS samples. Over
half the expressed miRNAs were found to be lower than in controls. (C) Graph showing the expression of the significantly down-regulated miRNAs in
TLE-HS samples. Individual Ct values from each TLE sample were normalized to the average of the Ct values from the control group. The graph
represents the average of the 22DDCt of each TLE sample. *p,0.05; **p,0.01; ***p,0.001 compared to control (from n=4 controls versus n=3 TLE-
HS samples). Note, Hsa is nomenclature denoting human miRNA sequence. (D) Graphs (n= 3–4 per group) showing expression (22DDCt, normalized to
Gapdh) for a selection of pri-miRNAs in the same control and TLE-HS samples.
doi:10.1371/journal.pone.0035921.g002
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[40,42,43,44], and transcription factors which regulate miRNA
levels continue to be identified [45].
How might loss of miRNA expression in TLE-HS tissue
contribute to disease pathogenesis? Broadly, a collapse of the
miRNA system would lead to the loss of a major mechanism
regulating expression of protein-coding genes which, as our
bioinformatics analysis supports, could impact diverse cellular
processes. More specifically, Dicer loss from astrocytes provokes
a reactive astrocytosis, which is known to contribute to seizure
generation [9,46]. Loss of miRNA biogenesis also produces
degenerative changes to dendritic morphology that have been
observed in experimental and human epilepsy [7]. A failure of
mature miRNA production due to Dicer deletion causes neuronal
death by apoptosis [7,9] and previous human data show higher
protein levels in TLE-HS for genes implicated in apoptosis,
including caspases [47]. Loss of certain miRNAs has been
implicated in neurodegenerative diseases, including miR-9* [48]
and miR-106b [49]. Both these miRNAs were present at lower
levels in TLE-HS samples in our study. Thus, reduced miRNA
levels may play a role in cell loss in TLE-HS, although whether
Figure 3. miRNA biogenesis components in neocortex and in experimental epilepsy. (A) Representative Western blots showing expression
of Dicer, Drosha and AGO2 in neocortex samples from TLE patients (TLE 9–11) and controls (C3–C5). (B) Graphs (n= 3 per group) showing semi-
quantification of levels of each protein. **p,0.05 compared to controls. Protein levels corrected to a-Tubulin (a-Tub). (C) Representative
immunohistochemistry illustrating the hippocampal damage in epileptic mice. (a) Field view (46 lens) showing triple-stained section from an
epileptic mouse 21 days after status epilepticus. Box highlights main lesion area in CA3. b,c are 206 lens field views of the lesioned CA3 area showing
reduced NeuN (red) and increased GFAP (green) staining. (D) Representative views of the CA3 from a control mouse at 21 days which did not
undergo status epilepticus. a–c show NeuN (red), GFAP (green) and a merge of these with DAPI overlay. Note the intact neuron population and
minimal GFAP staining. Scale bar in Ca, 500 mm; Cb, and Da, 100 mm. (E, F) Representative Western blots (n= 1 per lane) showing protein levels of
NeuN, GFAP, Dicer, Drosha and Ago2 in CA3 samples from control and epileptic (21 day) mice (TLE-HS). (G) Graph quantifying reduction in
hippocampal CA3 Dicer levels in epileptic animals (n= 7–8 per group; *p,0.05 compared to control). Protein levels corrected to a-Tub. (H)
Representative Western blots (n=1 per lane) show non-damaging seizures do not cause a reduction of Dicer levels. a-Tubulin is included as a guide
to protein loading.
doi:10.1371/journal.pone.0035921.g003
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neuron loss is a causal event in epileptogenesis remains debated
[50,51].
There are a number of potential caveats to consider in the
present study. Larger cohorts of patients, stratified for pathology
and/or seizure type and analysis of non-TLE epilepsy material will
be needed to corroborate our findings. Certain miRNAs were not
detected that might have been expected, for example miR-146a
which was reported to be over-expressed in TLE [25]. Another
potential confounder is anti-epileptic drug exposure. Our simu-
lated post-mortem interval experiments exclude any key finding
being an artefact of autopsy delay. Indeed, autopsy delay would
tend to underestimate the difference between control and TLE
samples. Finally, the use of the TLDA platform to quantify
miRNAs lacks the extensive coverage and quantitation possible
with deep sequencing, including the ability to detect variants of
mature miRNAs, such as isomiRs and mirtrons [52,53].
In summary, the present study provides evidence of dysfunction
of miRNA biogenesis in HS tissue from TLE patients. Future
efforts might be directed to determining whether restitution of
Dicer to such tissue restores mature miRNA production and
influences the epileptic phenotype.
Methods
Human Brain Tissue Samples
This study was approved by the Ethics (Medical Research)
Committee of Beaumont Hospital, Dublin (ERC/IRB 05/18) and
written informed consent was obtained from all patients. Control
(autopsy) hippocampus (n=4) and temporal cortex (n=3) was
obtained from five individuals from the NICHD Brain and Tissue
Bank for Developmental Disorders at the University of Maryland,
Baltimore, MD. Fresh frozen specimens were from individuals
without known neurological disease (Table 1). Patients (n=11)
were referred for surgical resection of the temporal lobe by an
epileptologist (N.D.) following neurological assessment, video-EEG
recording and MRI/neuroimaging. Each patient was determined
to have medically intractable TLE with an history of recurring
seizures (Table 2). All patients were taking anticonvulsant
medication prior to surgery. Patients underwent left or right
temporal lobe resection and the hippocampus and/or adjacent
neocortex was obtained. A portion of each specimen was retained
for pathology (see Table 2) with the remainder frozen in liquid
nitrogen and stored at –70uC until use. A pathologist (M.F.)
assessed hippocampus (n=8) and neocortex (n=3) as part of the
pathologic evaluation, addressed the degree of hippocampal
sclerosis, and described other pathologic changes. Each sample
was divided approximately equally and processed either for
miRNA extraction or protein analysis.
Animal Model of TLE
Animal experiments were performed in accordance with the
principles of the European Communities Council Directive (86/
609/EEC) and were approved by the Research Ethics Committee
of the Royal College of Surgeons in Ireland (REC 205).
Procedures were undertaken as previously described with mod-
ifications [21,22]. Adult male C57BL/6 mice (20–25 g) were
obtained from Harlan, UK. Briefly, mice were equipped with
skull-mounted EEG electrodes and a guide cannula under surgical
anaesthesia and then allowed to recover before triggering status
epilepticus by microinjection of kainic acid (Sigma-Aldrich,
Dublin, Ireland) into the basolateral amygdala nucleus (0.3 mg in
0.2 ml phosphate-buffered saline). Non-seizure control mice re-
ceived intraamygdala vehicle. After 40 min, mice were adminis-
tered lorazepam (6 mg/kg, i.p.) to curtail seizures and reduce
morbidity and mortality. Animals were euthanized 21 days later
and saline-perfused to remove intravascular blood components.
The CA3 subfield was extracted and processed for protein
analysis, as described [21]. To model brief non-harmful seizures,
mice received a single intra-peritoneal (i.p.) injection of kainic acid
(15 mg/kg). This causes mild behavioral changes, including
freezing and twitching but does not cause status epilepticus and
does not result in any neuronal death [21]. Animals were killed 4 h
later and brains processed as below.
miRNA Extraction and Expression Profiling
Total RNA was extracted from tissue samples using the
miRNeasy kit (Qiagen, West Sussex, UK) as per manufacturer’s
instructions to obtain an enrichment of small RNAs. Quality and
quantity of RNA was measured using a Nanodrop Spectropho-
tometer (Thermoscientific, Loughborough, UK) and RNA dilu-
tions made up in nuclease-free water. Reverse transcription of
100 ng of miRNA was carried out using stem-loop Multiplex
primer pools (Applied Biosystems, Paisley, U.K.). The miRNA
screen was carried out on the 7900HT Fast Realtime System using
TaqMan Low-Density Arrays (TLDA) (TaqMan TLDA Micro-
RNA Assays v1.0 containing 380 human microRNAs assays;
Applied Biosystems). A relative fold change in expression of the
target gene transcript was determined using the comparative cycle
threshold method (22DDCT). miRNAs were called present when
detected under the cut-off of 35 cycles of amplification in 3 out of 4
samples (controls) or 2 out of 3 (TLE patients). For comparative
expression analysis, data for each miRNA were normalized to the
average Ct value for each patient sample, as reported [54]. The Ct
is the number of cycles required for the fluorescent signal to cross
the threshold/background level. Thus, the lower the Ct value the
greater the amount of RNA in each sample, with a difference of
0.5–1 cycle in the Ct representing ,2 fold difference in expression
of the gene. A threshold of $1.5 fold was considered increased or
decreased compared to control, with statistical testing performed
using Student’s t-test, as elsewhere [55]. To visualize the data we
used Array Star software from DNASTAR (http://www.dnastar.
com) with control sample C4 used as the baseline. Hierarchical
clustering of the miRs was performed using an Euclidean distance
metric.
For miRNA specific primers and quantitative real-time PCR
[21], reverse transcription for individual qPCRs was carried out
using 100 ng of total RNA and the High-Capacity Reverse
Transcription Kit (Applied Biosystems). RT specific primers for
mouse miRNAs mmu-miR-19a, mmu-miR-132 and mmu-miR-
326 (Applied Biosystems) were used. Individual qPCRs were
carried out on the 7900HT Fast Realtime System (Applied
Biosystems) and RNU19 was used for normalization.
For analysis of primary transcripts (pri-miRNA), double-
stranded cDNA was synthesized from 176 ng RNA remaining
from samples C1–4 and TLE 1, 2 and 4, using SuperScript II
Reverse Transcriptase (Biosciences, Dun Laoghaire, Ireland).
Next, cDNA was amplified using the Pre-amplification Kit as
per manufacturer’s guidelines (Applied Biosystems). PCR analysis
was performed using cDNA in triplicate on the 7900 HT Fast
Realtime system (Applied Biosystems) for the following primary-
miRNA transcripts using Applied Biosystems pri-miRNA guide-
lines; pri-mir181d (Hs03303910_pri), pri-mir130a
(Hs03303108_pri), pri-let7d (Hs03302562_pri) and pri-mir23b
(Hs03303058_pri). Minus reverse-transcription and non-template
controls were routinely used to rule out genomic DNA and cross-
well contamination respectively. Gapdh (Hs99999905_m1) was
used for normalization. A relative fold change in expression
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compared to control was performed using the comparative cycle
threshold method (22DDCt).
miRNA Target Prediction Bioinformatics
Predicted mRNA targets of significantly regulated miRNAs
were identified using www.targetscan.org. For identification of the
most impacted GO (gene ontology) processes, lists of the top 30
highest scored mRNA targets based on pairing complementarity
[56] were analyzed using DAVID (http://david.abcc.ncifcrf.gov/).
Histology
Autopsy control and patient tissue sections were fixed and
stained with cresyl violet. GFAP immunohistohemistry was carried
out using anti-GFAP (Dako Diagnostics Ireland Ltd, Dublin,
Ireland), with diaminobenzdine enhancer on an automated
system. Slides were scanned on a Leica microsystems whole slide
imaging platform. For mouse studies, fresh frozen cryo-sections
(12 mm) were post-fixed, blocked in goat serum and incubated
with anti-NeuN (Millipore, Tullagreen, Co Cork, Ireland) and
anti-GFAP antibodies, followed by secondary antibodies conju-
gated to AlexaFluor 488 or 568, counterstaining with 49,6
diamidino-2-phenylindole (DAPI), as described [22]. Staining
was visualized using a Nikon2000s epifluorescence microscope and
images taken using a Hamamatsu Orca 285 camera.
Western Blotting
Western blotting was performed as previously described [21].
Briefly, samples were homogenized and lysed in buffer containing
a protease inhibitor cocktail. Protein (30 mg) was then separated by
8–10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis,
transferred to nitrocellulose membranes, and incubated with the
following antibodies: AGO2 and Drosha (Cell Signaling Technol-
ogy, Beverly, MA, USA), Dicer-1 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), NeuN (Millipore), GFAP and a-Tubulin
(Sigma-Aldrich Ireland Ltd, Arklow, Ireland). Membranes were
then incubated with horseradish peroxidase-conjugated secondary
antibodies (Jackson ImmunoResearch, Plymouth, PA, USA) and
bands visualized using Supersignal West Pico chemiluminescence
(Pierce, Rockford, IL, USA). Images were captured using a Fuji-
Film LAS-300 (Fuji, Sheffield, UK) and densitometry performed
using AlphaEaseFC4.0 gel-scanning integrated optical density
software (Alpha Innotech, San Leandaro, CA, USA).
Data Analysis
All data are presented as mean 6 s.e.m. Comparison of group
ages and protein densitometry was performed using unpaired t-
test. Significance was accepted at p,0.05.
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